Cite

HARVARD Citation

    Neuen, B. et al. (n.d.). Effects of canagliflozin on hyperkalaemia and serum potassium in people with diabetes and chronic kidney disease: insights from the CREDENCE trial. European heart journal. p. . [Online]. 
  
Back to record